ARDELYX, INC.

For the period ended Sep 30, 2026. Filed Nov 3, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 3, 2026

ARDX$2.93+1.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Statements of Changes in Stockholders’ Equity

(in thousands, except share amounts)

	Three Months Ended September 30, 2026
Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated OtherComprehensive Loss · Total Stockholders’ Equity
Shares · Amount
Balance as of June 30, 2026	249,147,061	$25	$1,150,446	$(1,001,265)	$(193)	$149,013
Issuance of common stock under employee stock purchase plan	214,774	—	690	—	—	690
Issuance of common stock upon exercise of options	151,203	—	269	—	—	269
Issuance of common stock upon vesting of restricted stock units	1,517,789	—	—	—	—	—
Stock-based compensation	—	—	15,101	—	—	15,101
Unrealized losses on available-for-sale securities	—	—	—	—	(290)	(290)
Net loss	—	—	—	(737)	—	(737)
Balance as of September 30, 2026	251,030,827	$25	$1,166,506	$(1,002,002)	$(483)	$164,046

	Nine Months Ended September 30, 2026
Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated OtherComprehensive Income (Loss) · Total Stockholders’ Equity
Shares · Amount
Balance as of December 31, 2025	244,351,501	$24	$1,113,666	$(946,939)	$198	$166,949
Issuance of common stock under employee stock purchase plan	351,254	—	1,432	—	—	1,432
Issuance of common stock for services	32,627	—	185	—	—	185
Issuance of common stock upon exercise of options	2,040,937	1	6,648	—	—	6,649
Issuance of common stock upon vesting of restricted stock units	4,254,508	—	—	—	—	—
Stock-based compensation	—	—	44,575	—	—	44,575
Unrealized losses on available-for-sale securities	—	—	—	—	(681)	(681)
Net loss	—	—	—	(55,063)	—	(55,063)
Balance as of September 30, 2026	251,030,827	$25	$1,166,506	$(1,002,002)	$(483)	$164,046

	Three Months Ended September 30, 2025
Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated OtherComprehensive (Loss) Income · Total Stockholders’ Equity
Shares · Amount
Balance as of June 30, 2025	240,765,516	$24	$1,085,108	$(945,563)	$(38)	$139,531
Issuance of common stock under employee stock purchase plan	162,859	—	703	—	—	703
Issuance of common stock upon exercise of options	860,811	—	2,111	—	—	2,111
Issuance of common stock upon vesting of restricted stock units	1,182,652	—	—	—	—	—
Stock-based compensation	—	—	12,742	—	—	12,742
Unrealized gains on available-for-sale securities	—	—	—	—	162	162
Net loss	—	—	—	(969)	—	(969)
Balance as of September 30, 2025	242,971,838	$24	$1,100,664	$(946,532)	$124	$154,280

	Nine Months Ended September 30, 2025
Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated OtherComprehensive Income · Total Stockholders’ Equity
Shares · Amount
Balance as of December 31, 2024	238,015,825	$24	$1,058,548	$(885,340)	$57	$173,289
Issuance of common stock under employee stock purchase plan	385,593	—	1,718	—	—	1,718
Issuance of common stock for services	87,256	—	315	—	—	315
Issuance of common stock upon exercise of options	1,641,801	—	3,566	—	—	3,566
Issuance of common stock upon vesting of restricted stock units	2,841,363	—	—	—	—	—
Stock-based compensation	—	—	36,517	—	—	36,517
Unrealized gains on available-for-sale securities	—	—	—	—	67	67
Net loss	—	—	—	(61,192)	—	(61,192)
Balance as of September 30, 2025	242,971,838	$24	$1,100,664	$(946,532)	$124	$154,280

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.